The very first of its kind commercial semiconductor field-effect transistor (FET) biosensor platform donated from Helios Bioelectronics Inc to collaborators at the Laboratory of Integrated Biomedical Micro/Nanotechnology & Applications, University of Illinois at Urbana-Champaign (LIBNA@UIUC). From left: Enrique Valera, Justin Liang, Yi-Shao Liu, Rashid Bashir, Katherine Koprowski, Janice Baek, Jongwon Lim.
Paving the way for your ideal Biomarkers
The BioFET (field-effect transistor) platform can detect any target with a net charge including nucleic acids (e.g. miRNA), proteins, bacteria, cells, etc. The BioFET chips are customizable through immobilization of target-specific probes onto the chip surface. Minimal sample preparation is required and no labeling is necessary for target detection. Over one million biosensors are contained on a single BioFET chip the size of a fingertip. This allows for detection of multiple targets on a single BioFET chip with significant statistical power.
POCT Empowered with Portable-sized BioFET Device
Fig.1. Discover the science behind the BioFET platform and its advantages in less than 2 min!
A strategic partnership and collaboration between Helios Bioelectronics Inc. and the Laboratory of Integrated Biomedical Micro/Nanotechnology & Applications (LIBNA), University of Illinois at Urbana-Champaign (UIUC)
With the donation of the first of its kind semiconductor FET biosensor platform, HBI will continue to foster a fruitful long term strategic partnership with LIBNA lab (UIUC), directed by Professor of Bioengineering Rashid Bashir, for in-depth research efforts to advance biosensor engineering technologies to deliver on the promise of digital healthcare.
At LIBNA, the Laboratory of Integrated Biomedical Micro/Nanotechnology & Applications, our vision in integrating biology and medicine with micro and nanotechnology can be categorized into two broad areas, namely how micro/nano-fabrication can help solve problems in life sciences (such as diagnostics, therapeutics, and tissue engineering), and how we can learn more from life science to solve important problems in micro/nano-science and engineering (such as bio-inspired self-assembly, etc.).
Founded in 2016, HBI is developing an application-driven and highly sensitive BioFET platform, enabling real-time monitoring of health status for precision medicine. The platform serves to collect diagnostic information such as genetic aberrations and altered protein expression for detecting and monitoring disease.
Fig. 2. The BioFET platform developed by Helios Bioelectronics Inc. A semiconductorbiosensor can be used for detection of various kinds of biological molecules.
董事長接受The Silicon Review訪問